{"result": "(\"entity\"<|>NIEMAN LK<|>PERSON<|>Nieman LK is a medical professional who has authored multiple guidelines on the treatment and diagnosis of Cushing's syndrome.)\n##\n(\"entity\"<|>UPTODATE INC<|>ORGANIZATION<|>UpToDate Inc. is a clinical decision support resource that provides evidence-based information for healthcare professionals.)\n##\n(\"entity\"<|>CUSHING'S SYNDROME<|>EVENT<|>Cushing's syndrome is a hormonal disorder caused by prolonged exposure to high levels of cortisol, often requiring medical treatment for management.)\n##\n(\"entity\"<|>WALTHAM<|>GEO<|>Waltham is a city in Massachusetts, USA, where UpToDate Inc. is located.)\n##\n(\"entity\"<|>PHILADELPHIA<|>GEO<|>Philadelphia is a city in Pennsylvania, USA, known for its historical significance and as the location of Elsevier, the publisher of the Williams Textbook of Endocrinology.)\n##\n(\"entity\"<|>ELSEVIER<|>ORGANIZATION<|>Elsevier is a publishing company that specializes in scientific, technical, and medical literature, including textbooks and journals.)\n##\n(\"entity\"<|>WILLIAMS TEXTBOOK OF ENDOCRINOLOGY<|>EVENT<|>The Williams Textbook of Endocrinology is a comprehensive medical textbook that covers various aspects of endocrinology, including the adrenal cortex.)\n##\n(\"relationship\"<|>NIEMAN LK<|>UPTODATE INC<|>Nieman LK has contributed to the guidelines published by UpToDate Inc. regarding the treatment of Cushing's syndrome<|>8)\n##\n(\"relationship\"<|>CUSHING'S SYNDROME<|>NIEMAN LK<|>Nieman LK has authored clinical practice guidelines for the treatment of Cushing's syndrome<|>9)\n##\n(\"relationship\"<|>CUSHING'S SYNDROME<|>WALTHAM<|>Cushing's syndrome is discussed in medical literature published by UpToDate Inc., which is based in Waltham<|>3)\n##\n(\"relationship\"<|>WILLIAMS TEXTBOOK OF ENDOCRINOLOGY<|>ELSEVIER<|>The Williams Textbook of Endocrinology is published by Elsevier, which is a major publisher of medical literature<|>7)\n##\n(\"relationship\"<|>WILLIAMS TEXTBOOK OF ENDOCRINOLOGY<|>CUSHING'S SYNDROME<|>The Williams Textbook of Endocrinology includes information on Cushing's syndrome and its treatment<|>6)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: • Nieman LK. Overview of the treatment of Cushing’s syndrome. UpToDate. Waltham, MA: UpToDate Inc. https://www.uptodate.com.\n                                                                                                                                                    Literature review current through: Apr. 2019.\n     10  En    ocasiones hay           que utilizar       tratamiento médico               para el control de la enfermedad                       • Nieman LK, Biller BMK, Findiling JW, Murad MH, Newel-Price J, Savage MO, et al. Treatment of Cushing’s syndrome:\n                                                                                                                                                    an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2015;100:2807-31.\n         de Cushing.          ¿Cuál de los siguientes               fármacos no se            considera bloqueante de                  la         • Nieman LK, Biller BMK, Findiling JW, Newel-Price J, Savage MO, Steward PM, e tal. The diagnosis of Cushing’s syndrome:\n         esteroidogénesis?                                                                                                                          an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2008;93:1526-40.\n                                                                                                                                                  • Steward PM, Newell-Price JDC. The adrenal cortex. En: Melmed S, Polonsky KS, Larsen PR, Kronenberg HM, eds. Williams Textbook\n                                                                                                                                                    of Endocrinology. 13.ª ed. Philadelphia: Elsevier; 2016. p. 490-555.\n         A.   Etomidato.\n         B.   Mifepristona.\n         C.   Metopirona.                                                                                                                     11  ¿Cuál de las siguientes no aparece en el síndrome de Cushing endógeno?\n         D.   Trilostano.                                                                                                                         A.   Pérdida de ritmo circadiano del cortisol.\n                                                                                                                                                  B.   Falta de respuesta del cortisol a la hipoglucemia insulínica.\n         COMENTARIO                                                                                                                               C.   Niveles elevados de ACTH.\n         Diversos fármacos que actúan directamente en las suprarrenales, inhibiendo la síntesis de                                                D.   Mutaciones inactivadoras en la subunidad alfa de la proteína G estimuladora (alpha\n         cortisol, tienen un papel importante en el tratamiento de la enfermedad de Cushing porque                                                     subunit of the stimulatory G protein of adenylyl cyclase), descritas en el síndrome de\n         son mucho más             efectivos que aquellos            que inhiben la        secreción hipofisaria de ACTH.                              McCune-Albright.\n         El ketoconazol, que inhibe varias enzimas de la esteroidogénesis, es el más utilizado.\n         La metopirona actúa fundamentalmente inhibiendo la 11-β-hidroxilasa y consiguiendo una                                                   COMENTARIO\n         disminución rápida de los niveles de cortisol. Con frecuencia se observa un fenómeno de                                                  En los sujetos sanos y en los pacientes con depresión endógena, la hipoglucemia inducida\n         escape que obliga a subir la dosis.                                                                                                      por insulina da lugar a una elevación de la concentración de ACTH y de cortisol, respues-\n         El mitotano, además de inhibir varias enzimas de la esteroidogénesis, tiene efectos adre-                                                ta que habitualmente no se observa en el síndrome de Cushing. En los pacientes sanos, la\n         nolíticos y se utiliza, fundamentalmente, en el tratamiento del carcinoma suprarrenal. Su                                                concentración plasmática de cortisol se halla en su valor máximo a primera hora de\n         comienzo de acción es lento, por lo que debe asociarse, inicialmente, a otros inhibidores de                                             la mañana, y alcanza su valor más bajo aproximadamente a medianoche. Este ritmo cir-\n         la  esteroidogénesis (ketoconazol o metopirona).                                                                                         cadiano se pierde en los pacientes con síndrome de Cushing, de modo que en la mayoría\n                                                                                                                                                  de   los   pacientes      el  cortisol plasmático            a  las  9  de la    mañana        es  normal, pero        los   valores\n                                                                                                                                                  nocturnos se hallan elevados.\n\n\n\n264                                                                                                                                                                                                                                                                                        265\n---\n                                                                                                                                                                                                                                 SUPRARRENALES                                            5\n\n\n\n         La enfermedad de McCune-Albright se debe a la presencia de mutaciones somáticas en el                                                      los   límites    de referencia       normal. En       el  50% restante,        se   halla moderadamente              elevada. La\n         GNAS, específicamente a mutaciones activadoras en la proteína Gsα, reguladora del AMPc.                                                    concentración de ACTH en el síndrome de ACTH ectópica es elevada; no obstante, se su-\n                                                                                                                                                    perpone con los valores observados en la enfermedad de Cushing en el 30% de los casos\n         Referencias:                                                                                                                               y, por consiguiente, no puede emplearse para diferenciar estas dos afecciones.\n         • Arlt W. Trastornos de la corteza suprarrenal. En: Kasper DL, Hauser SL, Jameson JL, Fauci AS, Longo DL, Loscazo J, eds\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}